Newsletter
| Promoter: | Crweselect.com | Paying Party: | UNKNOWN |
| Stocks covered: | Compensation: | Avg $ Volume for Period: |
| PSTI | Unknown compensation | UNKNOWN |
| Max Profit: 3.13 % | Gain at close: 1.45 % | |
| *We think that this promoter is a part of a group of promoters. | ||
It Gets Patent That Covers the Use of Adherent Placental Cells for the Treatment of Ischemia
(Mailing list information, including unsubscription instructions, is located at the end of this message.)
Pluristem Therapeutics, Inc. (PSTI)
Keep a close eye on PSTI. The company reported that it has been granted a new patent in Australia. Patent #2008300185, titled "Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced thereby for Therapy," covers the use of adherent placental cells for the treatment of ischemia, which is a restriction of blood supply to tissues, and for treatments of conditions requiring connective tissue repair or regeneration.
This is the 27th patent granted to PSTI and it adds to other countries in which the company has patent protection. This patent directly addresses indications that PSTI is currently developing for cardiovascular diseases including Intermittent Claudication, Critical Limb Ischemia and Acute Myocardial Infarction; orthopedic conditions including tendon injuries; and central nervous system conditions including Ischemic Stroke.
PSTI is a leading developer of placenta-based cell therapies. Its patented PLX (PLacental eXpanded) cells are a drug delivery platform that releases a cocktail of therapeutic proteins in response to a host of local and systemic inflammatory and ischemic diseases.
More about Pluristem Therapeutics, Inc. (PSTI) at www.pluristem.com
**
CAE Inc. (CAE)
CAE announced that it has won contracts valued at more than C$110 million, not including options, to provide a range of training systems and services for defence customers.
The contracts, which add to CAE's third quarter fiscal year 2014 order intake, include a new program to provide Beechcraft T-44C aircrew training for the United States Navy, a foreign military sale contract to provide an MH-60R Seahawk helicopter simulator for the Royal Danish Navy, and a contract from Beechcraft to provide a T-6C ground-based training system for the Mexican Air Force.
CAE is a global leader in modelling, simulation and training for civil aviation and defence.
More about CAE Inc. (CAE) at www.cae.com.
**
General Disclaimer: Statements on this website or newsletter may constitute forward-looking statements and are subject to numerous risks and uncertainties, including the failure to complete successfully the development of new or enhanced products, the Company’s future capital needs, the lack of market demand for any new or enhanced products the Company may develop, any actions by the Company’s partners that may be adverse to the Company, the success of competitive products, other economic factors affecting the Company and its markets, seasonal changes, and other risks detailed from time to time in the Company’s filings with the U.S. Securities and Exchange Commission. The actual results may differ materially from those contained on this website. The Company disclaims any obligation to update any statements in this website. These stock quotes and related data are provided for information purposes only and are not intended for trading purposes. Crown Equity Holdings Inc. will not be liable for any inaccuracies or delays in such data, or for any actions taken in reliance thereon. Potential investors should seek independent information and advice from qualified investment professionals prior to investment. Crown Equity Holdings Inc. provides links to websites operated by third parties. These links may be of interest or of use to you, and are provided for convenience only. You should be aware that in using these links, you are leaving Crown Equity Holdings Inc’s website. Crown Equity Holdings Inc. does not approve or endorse the content, information or materials available on such third party websites. In addition, Crown Equity Holdings Inc. makes no representation regarding, and is not responsible for, the content, information or material available on such websites. If you decide to access such websites or newsletter you do this at your own risk, and Crown Equity Holdings Inc. will not be liable for any loss or damage associated with your use of, or reliance on, the content, information or material available on such website.